Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
Abroad (travel likely)RecruitingPHASE4
Conditions
Hepatocellular Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Principal Investigator (Parissa Tabrizian)
Study leads
Parissa Tabrizian, MD
Principal Investigator
Mount Sinai Liver Cancer Program
Josep Llovet, MD, PhD
Principal Investigator
Icahn School of Medicine at Mount Sinai